Myeloablative Versus Reduced-Intensity Conditioning With Fludarabine/Busulfan for Myelodysplastic Syndrome: A Propensity Score-Matched Analysis-Reference-Cited by-同舟云学术

Myeloablative Versus Reduced-Intensity Conditioning With Fludarabine/Busulfan for Myelodysplastic Syndrome: A Propensity Score-Matched Analysis

Published:2022-06 Issue:6 Volume:28 Page:323.e1-323.e9
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Kurosawa Shuhei^ORCID,Shimomura Yoshimitsu,Itonaga Hidehiro,Najima Yuho,Kobayashi Takeshi,Ozawa Yukiyasu,Kanda Yoshinobu,Kako Shinichi,Kawakita Toshiro,Matsuoka Ken-ichi,Maruyama Yumiko^ORCID,Ota Shuichi,Nakazawa Hideyuki^ORCID,Imada Kazunori,Kimura Takafumi,Kanda Junya,Fukuda Takahiro,Atsuta Yoshiko^ORCID,Ishiyama Ken

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference59 articles.

1. Allogeneic stem-cell transplantation in patients with myelodysplastic syndromes and prevention of relapse;Franke;Clin Lymphoma Myeloma Leuk,2021

2. Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel;de Witte;Blood,2017

3. Transplantation for myelodysplastic syndromes: who, when, and which conditioning regimens;Saber;Hematology Am Soc Hematol Educ Program,2016

4. Allogeneic Hematopoietic Stem-Cell Transplantation for Acute Myeloid Leukemia in Remission: Comparison of Intravenous Busulfan Plus Cyclophosphamide (Cy) Versus Total-Body Irradiation Plus Cy As Conditioning Regimen—A Report From the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

5. Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI;Copelan;Blood,2013

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee;Blood;2024-05-30

2. Prognostic impact of the conditioning intensity on outcomes after allogeneic transplantation for MDS with low blasts: a nationwide retrospective study by the adult MDS working group of the Japan Society for Transplantation and Cellular Therapy;Bone Marrow Transplantation;2024-05-07

3. Comparison of Melphalan Dose in Patients with Myelodysplastic Syndrome Undergoing Allogeneic Transplantation with Reduced-Intensity Conditioning;Transplantation and Cellular Therapy;2024-05

4. Fludarabine plus reduced-intensity busulfan versus fludarabine plus myeloablative busulfan in patients with non-Hodgkin lymphoma undergoing allogeneic hematopoietic cell transplantation;Annals of Hematology;2023-01-12